Annex
United Kingdom
In Annex I to Directive 91/414/EEC the following rows are added at the end of the table:
Further details on identity and specification of active substances are provided in the review report.’
No Common name, identification numbers IUPAC name Purityf1 Entry into force Expiration of inclusion Specific provisions ‘123 Clothianidin
CAS No 210880-92-5
CIPAC No 738
(E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine ≥ 960 g/kg 1 August 2006 31 July 2016 PART A
Only uses as insecticide may be authorised.
PART B
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on clothianidin, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 27 January 2006 shall be taken into account.
In this overall assessment Member States
must pay particular attention to the protection of groundwater, when the active substance is applied in regions with vulnerable soil and/or climate conditions,
must pay particular attention to the risk to granivorous birds and mammals when the substance is used as a seed dressing.
Conditions of use shall include risk mitigation measures, where appropriate.
124 Pethoxamid
CAS No 106700-29-2
CIPAC No 655
2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl) acetamide ≥ 940 g/kg 1 August 2006 31 July 2016 PART A
Only uses as insecticide may be authorised.
PART B
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on pethoxamid, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 27 January 2006 shall be taken into account.
In this overall assessment Member States
must pay particular attention to the protection of groundwater, when the active substance is applied in regions with vulnerable soil and/or climate conditions,
must pay particular attention to the protection of the aquatic environment, in particular higher aquatic plants.
Conditions of use shall include risk mitigation measures, where appropriate.
The Member States shall inform the Commission in accordance with Article 13(5) on the specification of the technical material as commercially manufactured.
Annotations
Footnotes
- f1
-
Further details on identity and specification of active substances are provided in the review report.’